KONINKLIJKE PHILIPS NV (PHIA.AS)
NL0000009538 - Common Stock
Taking everything into account, PHIA scores 4 out of 10 in our fundamental rating. PHIA was compared to 55 industry peers in the Health Care Equipment & Supplies industry. PHIA may be in some trouble as it scores bad on both profitability and health. PHIA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
PHIA had positive earnings in the past year.
PHIA had a positive operating cash flow in the past year.
In multiple years PHIA reported negative net income over the last 5 years.
PHIA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of PHIA (-1.58%) is comparable to the rest of the industry.
The Return On Equity of PHIA (-3.87%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.58% | ||
| ROE | -3.87% | ||
| ROIC | N/A |
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHIA's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 41.00%, PHIA is not doing good in the industry: 70.37% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for PHIA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41% |
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
2. Health
2.1 Basic Checks
PHIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PHIA has been reduced compared to 1 year ago.
Compared to 5 years ago, PHIA has more shares outstanding
The debt/assets ratio for PHIA is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.70, we must say that PHIA is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.70, PHIA perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
The Debt to FCF ratio of PHIA is 4.76, which is a neutral value as it means it would take PHIA, 4.76 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.76, PHIA is in the better half of the industry, outperforming 75.93% of the companies in the same industry.
PHIA has a Debt/Equity ratio of 0.58. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
The Debt to Equity ratio of PHIA (0.58) is worse than 62.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | 4.76 | ||
| Altman-Z | 1.7 |
ROIC/WACCN/A
WACC6.27%
2.3 Liquidity
A Current Ratio of 1.20 indicates that PHIA should not have too much problems paying its short term obligations.
PHIA has a worse Current ratio (1.20) than 70.37% of its industry peers.
A Quick Ratio of 0.78 indicates that PHIA may have some problems paying its short term obligations.
PHIA's Quick ratio of 0.78 is on the low side compared to the rest of the industry. PHIA is outperformed by 68.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
PHIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.49%, which is quite impressive.
Measured over the past years, PHIA shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.67% on average per year.
The Revenue has been growing slightly by 0.36% in the past year.
PHIA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.05% yearly.
EPS 1Y (TTM)25.49%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS Q2Q%18.18%
Revenue 1Y (TTM)0.36%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Sales Q2Q%-0.7%
3.2 Future
The Earnings Per Share is expected to grow by 16.13% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.56% on average over the next years.
EPS Next Y17.07%
EPS Next 2Y13.73%
EPS Next 3Y13.94%
EPS Next 5Y16.13%
Revenue Next Year1.37%
Revenue Next 2Y3.14%
Revenue Next 3Y3.67%
Revenue Next 5Y4.56%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 18.55, the valuation of PHIA can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of PHIA indicates a rather cheap valuation: PHIA is cheaper than 85.19% of the companies listed in the same industry.
PHIA is valuated rather cheaply when we compare the Price/Earnings ratio to 24.41, which is the current average of the S&P500 Index.
PHIA is valuated correctly with a Price/Forward Earnings ratio of 14.80.
75.93% of the companies in the same industry are more expensive than PHIA, based on the Price/Forward Earnings ratio.
PHIA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.59, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.55 | ||
| Fwd PE | 14.8 |
4.2 Price Multiples
PHIA's Enterprise Value to EBITDA ratio is in line with the industry average.
PHIA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PHIA is cheaper than 96.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.71 | ||
| EV/EBITDA | 24.36 |
4.3 Compensation for Growth
PHIA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as PHIA's earnings are expected to grow with 13.94% in the coming years.
PEG (NY)1.09
PEG (5Y)N/A
EPS Next 2Y13.73%
EPS Next 3Y13.94%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.15%, PHIA is a good candidate for dividend investing.
PHIA's Dividend Yield is rather good when compared to the industry average which is at 2.33. PHIA pays more dividend than 100.00% of the companies in the same industry.
PHIA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
5.2 History
The dividend of PHIA decreases each year by -65.46%.
Dividend Growth(5Y)-65.46%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of PHIA are negative and hence is the payout ratio. PHIA will probably not be able to sustain this dividend level.
DP-0.43%
EPS Next 2Y13.73%
EPS Next 3Y13.94%
KONINKLIJKE PHILIPS NV
AMS:PHIA (7/26/2024, 7:00:00 PM)
23.74
-0.2 (-0.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap22.14B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.55 | ||
| Fwd PE | 14.8 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.09
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.58% | ||
| ROE | -3.87% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)25.49%
EPS 3Y-15.7%
EPS 5Y
EPS Q2Q%
EPS Next Y17.07%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)0.36%
Revenue growth 3Y1.62%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y